These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12666264)

  • 1. Developing therapy for acute ischemic stroke.
    Fisher M
    Therapie; 2002; 57(6):564-8. PubMed ID: 12666264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives on developing acute stroke therapy.
    Fisher M; Ratan R
    Ann Neurol; 2003 Jan; 53(1):10-20. PubMed ID: 12509843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy for acute ischemic stroke: 3 h and beyond.
    Padma V; Fisher M; Moonis M
    Expert Rev Neurother; 2005 Mar; 5(2):223-33. PubMed ID: 15853492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating acute ischemic stroke.
    Fisher M; Bastan B
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute ischemic stroke therapy.
    Henninger N; Kumar R; Fisher M
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1389-98. PubMed ID: 20936925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoteplase.
    Paciaroni M; Medeiros E; Bogousslavsky J
    Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoteplase in the treatment of acute ischemic stroke.
    Dafer RM; Biller J
    Expert Rev Neurother; 2007 Apr; 7(4):333-7. PubMed ID: 17425487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective acute stroke treatment beyond approval limitations: intravenous thrombolysis within an extended time window (3-6 h) and in old patients (aged 80 or older)].
    Thomalla G; Köhrmann M; Röther J; Schellinger PD
    Fortschr Neurol Psychiatr; 2007 Jun; 75(6):343-50. PubMed ID: 17366377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of cerebral ischemia.
    Ducruet AF; Grobelny BT; Zacharia BE; Hickman ZL; Yeh ML; Connolly ES
    Expert Opin Pharmacother; 2009 Aug; 10(12):1895-906. PubMed ID: 19514865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
    Jahan R; Vinuela F
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic reperfusion therapy in acute ischemic stroke.
    Martínez-Sánchez P; Díez-Tejedor E; Fuentes B; Ortega-Casarrubios MA; Hacke W
    Cerebrovasc Dis; 2007; 24 Suppl 1():143-52. PubMed ID: 17971650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
    Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
    J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.
    Külkens S; Hacke W
    Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ischemic penumbra: a new opportunity for neuroprotection.
    Fisher M
    Cerebrovasc Dis; 2006; 21 Suppl 2():64-70. PubMed ID: 16651816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.